Literature DB >> 22009319

NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

Edita Karosiene1, Claus Lundegaard, Ole Lund, Morten Nielsen.   

Abstract

A key role in cell-mediated immunity is dedicated to the major histocompatibility complex (MHC) molecules that bind peptides for presentation on the cell surface. Several in silico methods capable of predicting peptide binding to MHC class I have been developed. The accuracy of these methods depends on the data available characterizing the binding specificity of the MHC molecules. It has, moreover, been demonstrated that consensus methods defined as combinations of two or more different methods led to improved prediction accuracy. This plethora of methods makes it very difficult for the non-expert user to choose the most suitable method for predicting binding to a given MHC molecule. In this study, we have therefore made an in-depth analysis of combinations of three state-of-the-art MHC-peptide binding prediction methods (NetMHC, NetMHCpan and PickPocket). We demonstrate that a simple combination of NetMHC and NetMHCpan gives the highest performance when the allele in question is included in the training and is characterized by at least 50 data points with at least ten binders. Otherwise, NetMHCpan is the best predictor. When an allele has not been characterized, the performance depends on the distance to the training data. NetMHCpan has the highest performance when close neighbours are present in the training set, while the combination of NetMHCpan and PickPocket outperforms either of the two methods for alleles with more remote neighbours. The final method, NetMHCcons, is publicly available at www.cbs.dtu.dk/services/NetMHCcons , and allows the user in an automatic manner to obtain the most accurate predictions for any given MHC molecule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009319     DOI: 10.1007/s00251-011-0579-8

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  IMGT/HLA Database--a sequence database for the human major histocompatibility complex.

Authors:  J Robinson; M J Waller; P Parham; J G Bodmer; S G Marsh
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

3.  HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.

Authors:  Malene Erup Larsen; Henrik Kloverpris; Anette Stryhn; Catherine K Koofhethile; Stuart Sims; Thumbi Ndung'u; Philip Goulder; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-11-16       Impact factor: 2.846

4.  Efficient peptide-MHC-I binding prediction for alleles with few known binders.

Authors:  Laurent Jacob; Jean-Philippe Vert
Journal:  Bioinformatics       Date:  2007-12-14       Impact factor: 6.937

5.  NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Authors:  Thomas Stranzl; Mette Voldby Larsen; Claus Lundegaard; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-04-09       Impact factor: 2.846

6.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

7.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.

Authors:  Bjoern Peters; Alessandro Sette
Journal:  BMC Bioinformatics       Date:  2005-05-31       Impact factor: 3.169

8.  The immune epitope database 2.0.

Authors:  Randi Vita; Laura Zarebski; Jason A Greenbaum; Hussein Emami; Ilka Hoof; Nima Salimi; Rohini Damle; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

9.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

10.  Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research.

Authors:  Hong Huang Lin; Surajit Ray; Songsak Tongchusak; Ellis L Reinherz; Vladimir Brusic
Journal:  BMC Immunol       Date:  2008-03-16       Impact factor: 3.615

View more
  144 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome.

Authors:  Anne Bresciani; Sinu Paul; Nina Schommer; Myles B Dillon; Tara Bancroft; Jason Greenbaum; Alessandro Sette; Morten Nielsen; Bjoern Peters
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

3.  Improved methods for predicting peptide binding affinity to MHC class II molecules.

Authors:  Kamilla Kjaergaard Jensen; Massimo Andreatta; Paolo Marcatili; Søren Buus; Jason A Greenbaum; Zhen Yan; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

4.  Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Despoina Koumantou; Eilon Barnea; Adrian Martin-Esteban; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Harris Pratsinis; Dimitris Georgiadis; Lawrence J Stern; Arie Admon; Efstratios Stratikos
Journal:  Cancer Immunol Immunother       Date:  2019-06-20       Impact factor: 6.968

5.  NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.

Authors:  Kasper W Jørgensen; Michael Rasmussen; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

Review 6.  Cancer immunotherapy: moving forward with peptide T cell vaccines.

Authors:  Takumi Kumai; Aaron Fan; Yasuaki Harabuchi; Esteban Celis
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

7.  Automated benchmarking of peptide-MHC class I binding predictions.

Authors:  Thomas Trolle; Imir G Metushi; Jason A Greenbaum; Yohan Kim; John Sidney; Ole Lund; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Bioinformatics       Date:  2015-02-25       Impact factor: 6.937

8.  Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.

Authors:  Junfei Zhao; Andrew X Chen; Robyn D Gartrell; Andrew M Silverman; Luis Aparicio; Tim Chu; Darius Bordbar; David Shan; Jorge Samanamud; Aayushi Mahajan; Ioan Filip; Rose Orenbuch; Morgan Goetz; Jonathan T Yamaguchi; Michael Cloney; Craig Horbinski; Rimas V Lukas; Jeffrey Raizer; Ali I Rae; Jinzhou Yuan; Peter Canoll; Jeffrey N Bruce; Yvonne M Saenger; Peter Sims; Fabio M Iwamoto; Adam M Sonabend; Raul Rabadan
Journal:  Nat Med       Date:  2019-02-11       Impact factor: 53.440

9.  HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.

Authors:  Jatin Arora; Paul J McLaren; Nimisha Chaturvedi; Mary Carrington; Jacques Fellay; Tobias L Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-02       Impact factor: 11.205

10.  High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array.

Authors:  Amelia K Haj; Meghan E Breitbach; David A Baker; Mariel S Mohns; Gage K Moreno; Nancy A Wilson; Victor Lyamichev; Jigar Patel; Kim L Weisgrau; Dawn M Dudley; David H O'Connor
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.